{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-013213","form_type":"8-K","ticker":"MGRX","cik":"0001938046","company_name":"MANGOCEUTICALS, INC.","filed_at":"2025-09-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.651218+00:00","generated_at":"2026-05-17T06:47:09.356141+00:00","sec_items":["5.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Mangoceuticals grants 500k shares and 2M options to CEO; CFO and directors each receive 100k shares","bullets":["CEO Jacob Cohen receives 500,000 common shares as 2025 bonus and options to purchase 2,000,000 shares at $2.30.","Options vest over 18 months (500k per milestone); full acceleration on change of control or termination without cause.","CFO Eugene Johnston and directors Myers, Hamilton, D'Alessio each receive 100,000 fully vested common shares as 2025 bonuses."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-013213","json":"https://secwatch.observer/filing/0001493152-25-013213.json","markdown":"https://secwatch.observer/filing/0001493152-25-013213.md","text":"https://secwatch.observer/filing/0001493152-25-013213.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1938046/000149315225013213/0001493152-25-013213-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1938046/000149315225013213/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T06:47:09.356141+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}